ERGOTRATE MALEATE TABLET 1572 0.2MG .2 MG
ERGONOVINE MALEATE : .2 MG · DIN 00015709 · ELI LILLY CANADA INC
Health Canada status: CANCELLED POST MARKET
What is ERGOTRATE MALEATE TABLET 1572 0.2MG?
ERGOTRATE MALEATE TABLET 1572 0.2MG .2 MG contains ERGONOVINE MALEATE : .2 MG. It is listed in the Health Canada Drug Product Database under DIN 00015709, held by ELI LILLY CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00015709 |
|---|---|
| Brand name | ERGOTRATE MALEATE TABLET 1572 0.2MG |
| Generic / active ingredient | ERGONOVINE MALEATE : .2 MG |
| Manufacturer | ELI LILLY CANADA INC |
| Strength | .2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G02AB03 ERGOMETRINE |
| AHFS class | 76:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-1998 |
| Original market date | 1939-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code G02AB03 ERGOMETRINE. 1 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ERGONOVINE MALEATE INJECTION USP | 0.25 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02441241 |
| ERGONOVINE MALEATE INJECTION | 0.25 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED PRE MARKET | DIN 01996096 |
| ERGONOVINE MALEATE INJECTION USP | .25 MG | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00497312 |
| ERGONOVINE MALEATE INJECTION USP, 0.25MG/ML | 0.25 MG | SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02296144 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.